Published 1 day ago • loading... • Updated 1 day ago
Weight-loss jabs mean people need extra holes in their belts – Timpson boss
Around 2.4 million people in the UK are prescribed weight-loss medicines, while most semaglutide users still pay privately, officials said.
Timpson shops report a 680% increase in extra belt hole requests this year, reflecting surging demand for weight-loss jabs like Ozempic and Mounjaro.
Popularity of drugs like Ozempic, Mounjaro, and Wegovy has surged this year, with many people seeking weight-loss treatments despite NHS access restrictions.
James Timpson, chief executive of Timpson, said, "You can tell Ozempic and Mounjaro are popular," citing his shops' dramatic rise in belt adjustments.
Most people pay privately for weight-loss medications owing to restrictions on NHS access, limiting availability to eligible patients.
Some estimates suggest around 2.4 million people use weight-loss medications, illustrating the scale of this emerging health trend across the population.